Tablets (Disintegration & Dissolution)  Tablets   are solid preparations each containing a single dose of one or more   active  substances. They are obtained   by compressing uniform volumes of particles or by  another suitable manufacturing technique,   such as extrusion, moulding or freeze- drying (lyophilisation). Tablets are   intended for oral administration. Some are    swallowed whole, some after being chewed, some are dissolved or   dispersed in  water before being   administered and some are retained in the mouth where the active  substance is liberated.   The   particles consist of one or more active substances with or without   excipients  such as diluents, binders,   disintegrating agents, glidants, lubricants, substances  capable of modifying the behaviour of the   preparation in the digestive tract, colouring    matter authorised by the competent authority and flavouring   substances. Several categories of   tablets for oral use may be distinguished:   ·              uncoated tablets;   ·              coated tablets;   ·                 effervescent   tablets;  ·              soluble tablets;   ·              dispersible tablets;  ·              orodispersible tablets;  ·              gastro-resistant tablets;  ·              modified-release tablets;  ·              tablets for use in the mouth;  ·                 oral lyophilisates.   |  
Disintegration:
Type of Tablet  |   Media  |   Specification  |   For Out of   Specification  |  
UNCOATED   TABLETS  |   Water (37°C ± 2°C)  |   Not   More Than 15 minutes with disc  |   Repeat   the test on a further 6 Tablets  |  
Film-coated Tablets  |   Water (37°C ± 2°C)  |   Not   More Than 30 minutes with disc  |   Repeat   the test on a further 6 Tablets  |  
Enteric Coated Tablets  |   0.1 M hydrochloric   acid without disc (37°C ± 2°C)  (after   2 hours replace 0.1 M HCl Solution with the phosphate buffer)  |   2   hours remains intake  |   Repeat   the test on a further 6 Tablets  |  
phosphate buffer  solution   pH 6.8   (with disc)         (37°C ± 2°C)  |   Not More Than 60 minutes   with disc  |  ||
Effervescent Tablet  |   200 ml Water (15-25 °C)  |   Not   More Than 5 minutes   |   Repeat   the test on a further 5 Tablets  |  
Soluble Tablet  |   Water (15-25 °C)  |   Not   More Than 3 minutes   |   Repeat   the test on a further 6 Tablets  |  
Dispersible Tablets  |   Water (15-25 °C)  |   Not   More Than 3 minutes  |   -------  |  
Orodispersible Tablets  |   ------  |   Not   More Than 3 minutes  |   ------  |  
Dissolution: Four types of apparatuses   are now described in the British and European Pharmacopoeias; the basket, the paddle, the reciprocating   cylinder and the flow-through   cell. The descriptions are concordant with those published in the United   States Pharmacopeia (USP).    Of the   two established apparatuses (basket   and paddle) the paddle is now the apparatus of choice for many   preparations. However, where a published test uses the basket, work to   validate a change to the paddle method is not contemplated. The reciprocating   cylinder is useful for pH profiling studies while the flow-through cell may   be appropriate for preparations of poorly soluble active ingredients (see   Annex).  Test conditions The harmonised test conditions included in Appendix XII B1 will be applied to   all new monographs of the British Pharmacopoeia. It is not the intention of   the British Pharmacopoeia Commission to apply these criteria retrospectively   to existing monographs. Where an individual monograph prescribes the use of   the requirements stated under Monographs of the British Pharmacopoeia  in Appendix XII B1, the following conditions using the basket or paddle   apparatus are preferred.  Ø    rotation speed:100 rpm (basket), 50 rpm (paddle)  Ø    dissolution medium volume: 900 ml   Ø    dissolution medium composition: aqueous, commonly   0.1M hydrochloric acid  or phosphate buffers of pH 6.8 to 7.6  Ø    number of units tested: 6 (plus 6, if a retest is required).   The   number of units tested is specified in Appendix XII B1; other conditions are   specified in the relevant individual monographs.   In   situations where it has been demonstrated that the harmonised criteria are   not applicable (e.g. low solubility preparations, 'coning' of material in the   vessel, low concentration of analyte), modifications may be made to the test   conditions, such as, adding a surfactant, increasing the paddle rotation   speed or using a modified vessel and reducing the volume of dissolution   medium used.   |  
Dissolution:
Type of Tablet  |   Media  |   Specification  |   For Out of   Specification  |  
UNCOATED   TABLETS  |   0.1 M hydrochloric acid  / phosphate   buffer  solution / Water (37°C ± 0.5°C)  |   Should not be released   less than 70% of labeled amount at 45 minutes   |   Repeat   the test on a further 6 Tablets  |  
Film-coated Tablets  |   0.1 M hydrochloric acid  / phosphate   buffer  solution / Water(37°C ± 0.5°C)  |   Should not be released   less than 70% of labeled amount at 45 minutes  |   Repeat   the test on a further 6 Tablets  |  
Enteric Coated Tablets  |   (media for 2 hours) 0.1 M hydrochloric acid (37°C ± 0.5°C)  |   Should   not be released more than 10% of labeled amount after 2 hours  |   Repeat   the test on a further 6 Tablets  |  
Then   replace the 0.1 M HCl by phosphate   buffer    solution pH 6.8  (37°C ± 0.5°C)  |   Should   not be released less than 70% of labeled amount at 45 minutes  |  
Source: BP 2013 
